Exciting news for the Charcot-Marie-Tooth (CMT) community! The Hereditary Neuropathy Foundation (HNF) has been awarded an Advocacy Collaboration Grant from the Muscular Dystrophy Association (MDA) to further its groundbreaking work in CMT research. This funding will drive critical advancements in understanding how CMT affects mobility and quality of life—and we need YOU to be part of it!
As part of this initiative, HNF has partnered with BioSensics™ to conduct a pioneering wearable technology study designed to remotely monitor daily activities and functions of people living with CMT in real-world settings. This study utilizes FDA-registered wearable devices like PAMSys™, which continuously track movement, providing invaluable data that can help researchers and clinicians better understand CMT’s impact.
Why does this matter?
Shaping the Future of CMT Treatment – Real-world data is key to improving therapies and clinical trials.
Improving Patient Advocacy & Research – Your participation helps drive policy changes and better support for the CMT community.
Easy & Non-Invasive – The wearable device collects data seamlessly, requiring little effort from you!
Be a Part of This Game-Changing Study at the CMT Summit!
We are actively seeking participants aged 8-70 to join this important study at the upcoming HNF Clinical Trial Readiness Summit, happening April 24-26 in Nashville, TN. This is your chance to contribute to research, meet leading experts in the field, and connect with others in the CMT community.
Don’t Miss Out – Sign Up Now!
Be a driving force in the future of CMT treatments and research. Register for the HNF Summit and sign up for the wearable tech study today.
Have questions about the summit or wearable study?
Join us on zoom Wednesday, Feb. 27, 2025 anytime between 3:00pm – 4:00pm ET
0 Comments